Advanced search    

Search: authors:"R. Pisters"

6 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management

Geneesmiddelen). Funding No funds were received in support of this manuscript. Conflict of interest R. Pisters, A. Elvan, H.J.G.M. Crijns and M.E.W. Hemels declare that they have no competing interests. Open

Instantaneous wave-free ratio and fractional flow reserve in clinical practice

evaluate specific clinical settings. Conflict of interest R. Pisters, M. Ilhan, L.F. Veenstra, B.C.G. Gho, M. Stein, J.C.A. Hoorntje and S. Rasoul declare that they have no competing interests. Open Access

Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry

commercial party related directly or indirectly to the subject of this manuscript. The authors have no financial interest in the subject of this article. Conflict of interest R. Pisters, S.P.G. van Vugt, M.A

Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator

I. Limantoro K. Vernooy B. Weijs R. Pisters L. Debie H. J. Crijns Y. Blaauw Aims Atrial fibrillation (AF) and heart failure are conditions that often coexist. Consequently, many patients with an

Feasibility of TEE-guided stroke risk assessment in atrial fibrillation—background, aims, design and baseline data of the TIARA pilot study

, MaastrichtT. Dinh, H. Crijns, R. Pisters (133); Atrium Medical Center, HeerlenL. Baur (121); VU Medical Center, Amsterdam O. Kamp (22); Rijnstate Hospital, ArnhemJ. Lindeboom (7); VieCuri Medical Center